CONSTANCE FLYNN: Open Payments
NPI 1508120445 · PITTSFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 7 payments from 7 companies in 2025. Trend: 2023 $531 · 2024 $580 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $148 |
| KYOWA KIRIN, INC. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| ABIOMED | 1 | $104 |
| Lilly USA, LLC | 1 | $103 |
| Calliditas Therapeutics US Inc. | 1 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
Products named: REZDIFFRA, CRYSVITA, JARDIANCE, ZEPBOUND, TARPEYO, TZIELD.
Industry payments across MA — which companies pay providers there.
